LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 56.24 | 17.25 | 835 | 4929 | 0.1694 | 0.6089 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.21 | 17.25 | 12 | 4942 | 0.0024 | -0.0435 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.21 | 17.25 | 719 | 4942 | 0.1455 | 0.5793 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.21 | 17.25 | 52 | 4942 | 0.0105 | 0.1447 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.21 | 17.25 | 826 | 4942 | 0.1671 | 0.6064 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 60.18 | 17.25 | 14 | 5031 | 0.0028 | -0.0252 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 60.18 | 17.25 | 716 | 5031 | 0.1423 | 0.5762 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 60.18 | 17.25 | 37 | 5031 | 0.0074 | 0.0977 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 60.18 | 17.25 | 835 | 5031 | 0.1660 | 0.6061 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.15 | 17.25 | 2 | 5061 | 0.0004 | -0.2312 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.15 | 17.25 | 715 | 5061 | 0.1413 | 0.5752 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.15 | 17.25 | 27 | 5061 | 0.0053 | 0.0562 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.15 | 17.25 | 818 | 5061 | 0.1616 | 0.6013 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 65.12 | 17.25 | 6 | 5095 | 0.0012 | -0.1208 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 65.12 | 17.25 | 688 | 5095 | 0.1350 | 0.5670 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 65.12 | 17.25 | 13 | 5095 | 0.0026 | -0.0339 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 65.12 | 17.25 | 794 | 5095 | 0.1558 | 0.5946 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 67.09 | 17.25 | 1 | 5221 | 0.0002 | -0.2922 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 67.09 | 17.25 | 685 | 5221 | 0.1312 | 0.5632 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 67.09 | 17.25 | 9 | 5221 | 0.0017 | -0.0759 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 67.09 | 17.25 | 806 | 5221 | 0.1544 | 0.5943 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 69.06 | 17.25 | 1 | 5242 | 0.0002 | -0.2920 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 69.06 | 17.25 | 681 | 5242 | 0.1299 | 0.5615 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 69.06 | 17.25 | 8 | 5242 | 0.0015 | -0.0890 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 69.06 | 17.25 | 780 | 5242 | 0.1488 | 0.5875 | MN20160310_N02 | N03 |